Pages that link to "Q40243873"

The following pages link to Design and synthesis of a series of novel pyrazolopyridines as HIF-1alpha prolyl hydroxylase inhibitors (Q40243873):

Displaying 21 items.

• Inhibition of 2-oxoglutarate dependent oxygenases (Q28306956) (← links)
• Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease (Q33402434) (← links)
• Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis (Q34169514) (← links)
• 3,6-Dimethyl-1-phenyl-4-(2-thien-yl)-8-(2-thienylmethyl-ene)-5,6,7,8-tetra-hydro-1H-pyrazolo[3,4-b][1,6]naphthyridine (Q34295672) (← links)
• Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases (Q34657382) (← links)
• A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection (Q36712172) (← links)
• Cellular oxygen sensing in health and disease (Q36978952) (← links)
• Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets (Q37374651) (← links)
• Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia (Q37779100) (← links)
• Structure-based drug design for hypoxia-inducible factor prolyl-hydroxylase inhibitors and its therapeutic potential for the treatment of erythropoiesis-stimulating agent-resistant anemia: raising expectations for exploratory clinical trials (Q38103912) (← links)
• Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy (Q38577907) (← links)
• Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications. (Q38648760) (← links)
• Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues (Q39156241) (← links)
• Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion. (Q39244944) (← links)
• Synthesis of some pyrazolines and pyrimidines derived from polymethoxy chalcones as anticancer and antimicrobial agents (Q39507009) (← links)
• Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptation (Q39711306) (← links)
• Synthesis and biological evaluation of some novel tetrahydroquinolines as anticancer and antimicrobial agents (Q43430324) (← links)
• Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation (Q46863123) (← links)
• Structural Insight into the Prolyl Hydroxylase PHD2: A Molecular Dynamics and DFT Study (Q56701681) (← links)
• Synthesis and anticancer evaluation of novel isoxazole/pyrazole derivatives (Q59203753) (← links)
• A Versatile Protocol for the Synthesis of Pyrazolyl-Substituted Pyridinium and Guanidinium Salts from Pyridone and Urea Derivatives (Q64169355) (← links)